Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06323824
PHASE4

Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.

Sponsor: Yale University

View on ClinicalTrials.gov

Summary

The purpose of this clinical trial is to compare the effectiveness of office-based methadone with pharmacy administration and/or dispensing to office-based buprenorphine for the treatment of opioid use disorder. This study will also examine factors influencing the implementation of office-based methadone.

Official title: Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment - A Pragmatic Hybrid Effectiveness/Implementation Trial

Key Details

Gender

All

Age Range

18 Years - 99 Years

Study Type

INTERVENTIONAL

Enrollment

600

Start Date

2024-06-04

Completion Date

2029-05

Last Updated

2025-10-30

Healthy Volunteers

No

Interventions

DRUG

Methadone

Drug: Methadone Possible formulations: 10 and 50 mg tablets

DRUG

Buprenorphine (BUP)

Drug: Buprenorphine (BUP) Possible formulations: A. Buprenorphine 225 mcg to 24 mg 225 mcg to 32 mg per day B. Buprenorphine (Extended release) 300 mg q 28 days (Sublocade) 100 mg q 28 days (Sublocade) 8 mg q 7 days (Brixadi) 16 mg q 7 days (Brixadi) 24 mg q 7 days (Brixadi) 32 mg q 7 days (Brixadi) 64 mg q 7 28 days (Brixadi) 96 mg q 7 28 days (Brixadi) 128 mg q 7 28 days (Brixadi)

Locations (6)

Highland Hospital Bridge Clinic at Alameda Health System

Oakland, California, United States

Outpatient Buprenorphine Induction Clinic, University of California, San Francisco

San Francisco, California, United States

Rapid Start Clinic, Kaiser Permanente Colorado

Denver, Colorado, United States

Officed Based Addiction Treatment Program, Boston Medical Center

Boston, Massachusetts, United States

Hennepin Healthcare Addiction Medicine

Minneapolis, Minnesota, United States

Marshall University Division of Addiction Sciences P.R.O.A.C.T

Huntington, West Virginia, United States